Researchers Identify Biomarker for Glaucoma Damage
Today, RPB-supported researchers at Washington University School of Medicine in St. Louis published a study identifying a biomarker that could help to predict glaucoma damage before vision loss.
An optic nerve with glaucoma damage, signified by loss of color and a round rim of pink tissue within the nerve.
Photo credit: CARLA J. SIEGFRIED / Washington University School of Medicine in St. Louis
"There hasn't been a reliable way to predict which patients with glaucoma have a high risk of rapid vision loss," said principal investigator Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences.
"But we've identified a biomarker that seems to correlate with disease severity in patients, and what that marker is measuring is stress to the cells rather than cell death. Other glaucoma tests are measuring cell death, which is not reversible, but if we can identify when cells are under stress, then there's the potential to save those cells to preserve vision," said Dr. Apte.
May 4, 2017
Related News: Feature Story, Glaucoma, Top Story
RPB Hosts Virtual Glaucoma Event
RPB grantees provide expert advice on glaucoma in the first event of the "Lunch & Learn" series.
RPB and Partners Launch the scEYEnce Campaign
This new media campaign shines a spotlight on the powerful benefits of vision research.
RPB and Association of University Professors of Ophthalmology Announce 2021 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
David Williams, PhD, is recognized for ground-breaking contributions to the field of vision research.
Former RPB Grantee Dr. Michael Chiang Named Director of National Eye Institute
Dr. Chiang is a respected scientist, clinician and leader in vision research.
Research to Prevent Blindness Expands Career Development Award
RPB is increasing both the amount of funding and the number of awards funded through its flagship grant in order to better support early-career vision scientists.
Research to Prevent Blindness and Allergan Foundation Announce New Partnership to Support Early-Career Vision Researchers
The organizations announce new grants to increase funding for innovative research from early-career vision scientists.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2021 Research to Prevent Blindness. All Rights Reserved.
